Sci Pharmtech is an API manufacturer based in Taiwan. It holds 13 active US drug master files across a filed portfolio of 15 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 6 June 2025 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Taiwan, Taiwan | 3004065859 |
| Molecule | Regulators | Docs |
|---|---|---|
| Valproic Acid | SFDA (Saudi Arabia), US FDA | 3 |
| Sodium Valproate | SFDA (Saudi Arabia) | 2 |
| Adenine | US FDA | 1 |
| Allopurinol | US FDA | 1 |
| Articaine | US FDA | 1 |
| Atomoxetine | US FDA | 1 |
| Brinzolamide | US FDA | 1 |
| Cannabidiol | US FDA | 1 |
| Clindamycin | US FDA | 1 |
| Duloxetine | US FDA | 1 |
| Duloxetine Hydrochlorie | SFDA (Saudi Arabia) | 1 |
| Hydroxychloroquine | US FDA | 1 |
| Loxoprofen | US FDA | 1 |
| Probucol | US FDA | 1 |
| Propafenone | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | None | 1 |
Choose your molecules and target markets. Sci Pharmtech comes back tiered against every other supplier able to file there.
Start for free